rs186508321
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS2BP4
This summary comes from the ClinGen Evidence Repository: The p.Gly428Val variant is observed in at least 2 unaffected individuals (internal database) (BS2). Computational analysis prediction tools suggest that the p.Gly428Val variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Gly428Val variant in TCF4 is classified as likely benign based on the ACMG/AMP criteria (BS2, BP4). LINK:https://erepo.genome.network/evrepo/ui/classification/CA300814398/MONDO:0012589/016
Frequency
Consequence
NM_001083962.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TCF4 | NM_001083962.2 | c.1283G>T | p.Gly428Val | missense_variant | 15/20 | ENST00000354452.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TCF4 | ENST00000354452.8 | c.1283G>T | p.Gly428Val | missense_variant | 15/20 | 5 | NM_001083962.2 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152122Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 250912Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135614
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461530Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 727068
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74438
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 18, 2019 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously reported as pathogenic or benign in association with a TCF4-related disorder. The variant has been observed in a patient with schizophrenia and was not identified in 305 control individuals; however, no additional information was provided (Hu et al., 2014).; This variant is associated with the following publications: (PMID: 24126932) - |
Uncertain significance, no assertion criteria provided | clinical testing | New York Genome Center | Nov 14, 2019 | - - |
Pitt-Hopkins syndrome Benign:2
Likely benign, reviewed by expert panel | curation | ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel | Mar 26, 2021 | The p.Gly428Val variant is observed in at least 2 unaffected individuals (internal database) (BS2). Computational analysis prediction tools suggest that the p.Gly428Val variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Gly428Val variant in TCF4 is classified as likely benign based on the ACMG/AMP criteria (BS2, BP4). - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 20, 2023 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at